Why the study?
Does low-dose aspirin reduce the risk of incident frailty or the trajectory of frailty in community-dwelling healthy older adults?
Does low-dose aspirin reduce the risk of incident frailty or the trajectory of frailty in community-dwelling healthy older adults?
Initiation of low-dose aspirin in healthy older adults does not prevent or slow the progression of frailty.
Answers are grounded in this paper and cite their sources.
No role for low-dose aspirin in frailty prevention among healthy older adults; confirms null effect on this outcome in primary prevention.
Low-dose aspirin use in healthy older adults when initiated in older ages does not reduce risk of incident frailty or the trajectory of frailty.
No takes yet. Share an insight, caveat, or question.
Espinoza et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: